Search results
Sen. Hassan slams GlaxoSmithKline over cost of asthma inhalers
New Hampshire Union Leader· 2 days agoPharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a...
Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
The Hill· 2 days agoDrug manufacturing giant GlaxoSmithKline (GSK) is subverting its pledge to lower the price of its...
5 best blue chip stocks to invest in for sustainable gains in May - excluding Apple Inc. (AAPL) |...
Invezz· 1 day agoYesterday, the biggest company in the world in terms of market cap reported its latest earnings....
GSK profit drops in first quarter on higher costs
Digital Journal· 3 days agoBritish drugmaker GlaxoSmithKline on Wednesday said its net profit fell 23 percent in the first quarter as the company faced higher exceptional costs...
Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism
The Wall Street Journal· 6 days agoHis lab there found that resveratrol appeared to prolong the lifespan of mice. Sinclair was one of...
Suddenly, Chinese Spies Seem to Be Popping Up All Over Europe
The New York Times via Yahoo News· 7 days agoOne of the men, a young Briton known for his hawkish views on China, worked as an aide to a...
Competition from 'skinny label' generics saved medicare billions, according to report
Medical Xpress· 18 hours agoAn analysis of 15 name-brand drugs and their "skinny label" generic counterparts found that...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition - KVIA
ABC 7 El Paso· 4 days agoBy MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — The Federal Trade Commission is challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic. Tuesday ...
Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Medscape· 1 day agoRecent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 4 days agoThe FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, AstraZeneca, ...